Med Spas NAICS 812199

Jul 18, 2025 - Cosmetic Procedures Up 42% Over Four-Year Period: Report

• The most popular non-surgical procedures performed by plastic surgeons in 2024 were botulinum toxin, hyaluronic acid (filler), hair removal, non-surgical skin tightening, and chemical peels, according to a new Global Survey on Aesthetic/Cosmetic Procedures from the International Society of Aesthetic Plastic Surgery (ISAPS). The report showed that 17.4 million surgical procedures and 20.5 million non-surgical procedures were performed by plastic surgeons in 2024, an increase of 42.5% in cosmetic procedures over the last four years. The countries that performed the most procedures were the US (6.1 million), Brazil (3.1 million), and Japan (1.6 million). In the US, the most popular non-surgical aesthetic procedures were botulinum toxin (1.7 million), hyaluronic acid (1.2 million), non-surgical skin tightening (356,072), chemical peel (170,203), and hair removal (157,756). The most common non-surgical procedure for both men and women, and among all age groups, was botulinum toxin injectables, with 7.8 million procedures performed worldwide.
• The University of Michigan’s consumer sentiment index increased slightly in July 2025, rising to 61.8 in preliminary July data from 60.7 in June, according to a report in the Wall Street Journal. The consumer sentiment index hit a recent peak of 74 in December, buoyed following the presidential election, but dropped to 52.2 in April 2025 as consumers expressed uncertainty about tariff effects and rising inflation. The record low of the index during the past 10 years was in June 2022, when it reached 50. In July, respondents’ inflation expectations for the coming year were a predicted increase of 4.4%, higher than in January, when respondents expected prices to grow by 3.9%. However, July’s inflation expectation results were lower than June’s, when respondents expected a 5% price increase for the coming year. The index serves as a predictor of consumer spending as it indicates consumers’ perception of their financial prospects and the broader economy.

• US spa revenue, locations, and visits are growing, according to the annual US Spa Industry Study report results in Skin Inc. The study is commissioned by the International SPA Association (ISPA), which includes med spa members, and conducted by PwC. Overall revenue at US spas increased 5.8% in 2024 to $22.5 billion year over year. Total spa visits rose 3.1%, reaching 187 million in 2024, while the number of spa locations grew year over year 0.6% to 21,980 in 2024. The report noted that 30% of properties surveyed said they’d renovated their retail in 2024, and 25% had improved their treatment rooms. Revenue per visit also grew 2.6% year over year in 2024, reaching $120.30 in 2024. In addition, spa industry employment increased 1.6% year over year in 2024.
• Med spas are monitoring potential impacts of recent tariffs implemented by the Trump administration on cosmetic injectables and fillers, which could raise the prices of beauty procedures and enhancements, according to a report on MSN.com. The level of price increases depends on the percentage of the tariff and where the injectable is sourced from. According to Dr. Sean McNally, “Most neurotoxin supplies come from Europe, Botox and Juvéderm are produced in Ireland and France, respectively, so any EU tariffs would affect pricing for those. Daxxify is made in the US, so it may be a big winner in this scenario.” McNally noted that clients who currently use Boxtox and fillers are on a regular maintenance schedule for best results and would be impacted by any price increases.